{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:05:51Z","timestamp":1790521551590,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.tiv.2019.104619","type":"journal-article","created":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T11:19:45Z","timestamp":1565003985000},"page":"104619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Development of an in vitro cholestatic drug-induced liver injury evaluation system using HepG2-hNTCP-C4 cells in sandwich configuration"],"prefix":"10.1016","volume":"61","author":[{"given":"Yoko","family":"Sakai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Iwao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Watashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kousei","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamihide","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2019.104619_bb0005","doi-asserted-by":"crossref","first-page":"28857","DOI":"10.1074\/jbc.M011610200","article-title":"Human bile salt export pump promoter is transactivated by the farnesoid X receptor\/bile acid receptor","volume":"276","author":"Ananthanarayanan","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tiv.2019.104619_bb0010","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1517\/17425255.2012.685159","article-title":"The HepaRG cell line: a unique in vitro tool for understanding drug metabolism and toxicology in human","volume":"8","author":"Andersson","year":"2012","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.tiv.2019.104619_bb0015","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/toxsci\/kfv041","article-title":"Comparative localization and functional activity of the main hepatobiliary transporters in HepaRG cells and primary human hepatocytes","volume":"145","author":"Bachour-El Azzi","year":"2015","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2019.104619_bb0020","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1124\/dmd.105.009118","article-title":"Use of cryopreserved human hepatocytes in sandwich culture to measure hepatobiliary transport","volume":"34","author":"Bi","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2019.104619_bb0025","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0041-008X(03)00128-5","article-title":"An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons","volume":"189","author":"Brandon","year":"2003","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tiv.2019.104619_bb0030","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1002\/jps.23933","article-title":"Confocal imaging with a fluorescent bile acid analogue closely mimicking hepatic taurocholate disposition","volume":"103","author":"De Bruyn","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.tiv.2019.104619_bb0035","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1021\/mp300453k","article-title":"Structure-activity relationship for FDA approved drugs as inhibitors of the human sodium taurocholate cotransporting polypeptide (NTCP)","volume":"10","author":"Dong","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.tiv.2019.104619_bb0040","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.taap.2013.03.019","article-title":"ATP-dependent transport of statins by human and rat MRP2\/Mrp2","volume":"269","author":"Ellis","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tiv.2019.104619_bb0045","doi-asserted-by":"crossref","first-page":"10629","DOI":"10.1073\/pnas.88.23.10629","article-title":"Functional expression cloning and characterization of the hepatocyte Na+\/bile acid cotransport system","volume":"88","author":"Hagenbuch","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tiv.2019.104619_bb0050","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2133\/dmpk.18.16","article-title":"Potential cholestatic activity of various therapeutic agents assessed by bile canalicular membrane vesicles isolated from rats and humans","volume":"18","author":"Horikawa","year":"2003","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.tiv.2019.104619_bb0055","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.bbrc.2013.12.052","article-title":"Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP","volume":"443","author":"Iwamoto","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tiv.2019.104619_bb0060","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.humpath.2009.07.003","article-title":"Hep G2 is a hepatoblastoma-derived cell line","volume":"40","author":"Lopez-Terrada","year":"2009","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.tiv.2019.104619_bb0065","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1007\/s11095-009-9896-0","article-title":"Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs","volume":"26","author":"Matsson","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.tiv.2019.104619_bb0070","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/cyto.a.22105","article-title":"Expression of cyclins in high-density cultured cells and in vivo tumor cells","volume":"81","author":"Min","year":"2012","journal-title":"Cytometry A."},{"key":"10.1016\/j.tiv.2019.104619_bb0075","doi-asserted-by":"crossref","first-page":"427","DOI":"10.18433\/J3801T","article-title":"Tacrine sinusoidal uptake and biliary excretion in sandwich-cultured primary rat hepatocytes","volume":"17","author":"Mohamed","year":"2014","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.tiv.2019.104619_bb0080","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/toxsci\/kfq269","article-title":"Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development","volume":"118","author":"Morgan","year":"2010","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2019.104619_bb0085","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/toxsci\/kft176","article-title":"A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development","volume":"136","author":"Morgan","year":"2013","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2019.104619_bb0090","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/toxsci\/kfu122","article-title":"Different dose-dependent mechanisms are involved in early cyclosporine a-induced cholestatic effects in hepaRG cells","volume":"141","author":"Sharanek","year":"2014","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2019.104619_bb0095","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1124\/dmd.115.065425","article-title":"Prediction of the clinical risk of drug-induced cholestatic liver injury using an in vitro sandwich cultured hepatocyte assay","volume":"43","author":"Susukida","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2019.104619_bb0100","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.tiv.2015.06.004","article-title":"Basal efflux of bile acids contributes to drug-induced bile acid-dependent hepatocyte toxicity in rat sandwich-cultured hepatocytes","volume":"29","author":"Susukida","year":"2015","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.tiv.2019.104619_bb0105","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.xphs.2016.01.013","article-title":"Establishment of a drug-induced, bile acid-dependent hepatotoxicity model using HepaRG cells","volume":"105","author":"Susukida","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.tiv.2019.104619_bb0110","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1021\/mp900227a","article-title":"Influence of seeding density and extracellular matrix on bile acid transport and mrp4 expression in sandwich-cultured mouse hepatocytes","volume":"7","author":"Swift","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.tiv.2019.104619_bb0115","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1124\/dmd.114.061580","article-title":"Interspecies variability in expression of hepatobiliary transporters across human, dog, monkey, and rat as determined by quantitative proteomics","volume":"43","author":"Wang","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2019.104619_bb0120","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1124\/jpet.102.044107","article-title":"Pharmacokinetics of 5 (and 6)-carboxy-2\u2032,7\u2032-dichlorofluorescein and its diacetate promoiety in the liver","volume":"304","author":"Zamek-Gliszczynski","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088723331930030X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088723331930030X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:34:44Z","timestamp":1760135684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088723331930030X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":24,"alternative-id":["S088723331930030X"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2019.104619","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of an in vitro cholestatic drug-induced liver injury evaluation system using HepG2-hNTCP-C4 cells in sandwich configuration","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2019.104619","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104619"}}